C110077N_Vital.indb

Similar documents
untitled

4. 27(2) ,000,000 1,000,000,

A 20%

, ,225 (162,513) (158,904) 76,828 69, ,552 2, ,625 (27,890) (21,426) (21,265) 8 (1,689) (1,113) 29


4 37,919 40,859 6 (1,752) (10,323) 36,167 30,536 35,919 30, (430) 36,167 30,


4. 27(2) ,000,000,

C110122D_Vitar.indb

, ,249 (164,579) (77,591) 128, ,658 31,085 13,783 (67,320) (60,839) (118,382) (60,344) (24,438) (52,355)

5 11,949,401 14,705,163 (10,285,277) (9,119,336) (4,000,836) (3,078,877) (5,859,443) (6,090,711) (924,836) (795,886) (8,236,323) (11,529,150) 391,234

4 3,379,679 3,207,224 (2,574,040) (2,479,550) 805, , ,999 66,818 (435,016) (374,193) (90,274) (97,935) (138) (157) 5 367, ,207 6 (7

i

目 錄 頁 次 釋 義 董 事 會 函 件 言

C Ann.indd


Glorious Property Holdings Limited ,374 1, , % 1, ,895 1

UKF (HOLDINGS) LIMITED Kopenhagen Fur Auction 2,000,000 50% 75% 1

,787,321 6,292,569 (3,178,103) (3,422,560) 2,609,218 2,870, ,824 85,775 (1,766,182) (2,108,497) (477,730) (536,273) (79,000) (98,0

REDCO PROPERTIES GROUP LIMITED % 3, , % % 20.5%

REDCO PROPERTIES GROUP LIMITED % 1, % 1, % , %

3 51,115,551 37,662,173 14,041,946 14,048,008 (12,294,931) (13,969,624) (4,241,232) (5,114,524) 38,820,620 23,692,549 9,800,714 8,933,484 3,648,828 52


i

,801,000 1,473,691 20,764 12,778 (548,084) (452,982) (483,269) (395,241) (97,289) (66,548) (278,473) (209,777) (85,45

China Water_C_GM Cir.indb

2

, ,171 (188,495) (213,231) 435, , ,024 30,302 (305,546) (319,034) (56,225) (69,190) (1,876) (1

1

Jiayuan International Group Limited , ,787, % 52% , , % % 3,



cover-C- FINAL.ai

書冊392.indb

C Ann.indd

7,590 7,723 (1,436) (1,558) 6,154 6,165 (774) (2,155) 5,380 4,010 23,981 29,361 4,010 5,672 2,912 (292) 1,098 5,380 4,

2,053, ,367 2,410, , , , , , , ,360 97, ,920 6,370,055 5,700,000 5,853,

3 707, ,007 (411,337) (371,384) 296, , ,184 4,764 (2,789) (2,194) (69,458) (32,844) (1,595) (73) 4 (102,545) (109,848) (107) 8 125,1


7 1,142, ,713 9 (920,417) (795,244) 221, , ,013 2, ,593 42,664 9 (52,237) (39,466) 9 (77,748) (77,768) 112,236 76,


Billion_C_GM Cir.indb

% %

, ,841 6,987 5,843 (249,969) (250,800) (280,359) (257,471) (53,934) (53,676) (157,644) (166,844) (45,059) (43,359)

, ,499 (622,462) (586,764) 146, ,735 (13,054) (12,363) (30,564) (24,768) (60,370) (78,336) (4,099) (4,907) 6

SOHO 104,555,000 63,904,0 61% 145,783,0


( ) :

% (EBITDA) % % %


, ,451 6,960 13,753 (270,195) (277,870) (263,052) (243,969) (55,147) (46,161) (147,150) (135,197) (47,944) (4

i


2011 1

00C AR.indb

: O16

untitled


巨騰國際控股有限公司

5 25,347 26,359 (9,642) (12,913) 15,705 13, ,951 3,954 (8,797) (43,127) 7 (53,776) (1,409) (6,837) (80,268) (84,388) 8 (12,581) (13,316) (31) 9


18,840,000 16,320, %(i) (ii) 30,520,000 11,170,000 (i) (ii) 2

: 1966.HK 2017

目 錄 公 司 資 料 釋 義 財 務 概 要 集 團 架 構 行 政 總 裁 報 告 管 理 層 討 論 及 分 析 董 事 及 高 級 管 理 層 簡 介 企 業 管 治 報 告 董 事 會 報 告 獨 立 核 數 師 報 告 經 審 核 財 務 報 表

Hao Wen_C_AR.indb

i

Pine Care Group Limited % % 13.5 EBITDA 1.5% 32.6 EBITDA 19.9% 32.1 EBITDA EBITDA EBITDA

1


C110443A_Vital.indd

5 212, ,902 (70,641) (67,902) 141, , ,943 3,014 (65,496) (57,985) (66,271) (61,919) (1,804) (1,333) (4,594) (6,018) 6 10,386 (5,241)




RM GROUP HOLDINGS LIMITED 932 % 96,174 97, % 74,000 74, % EBIT 1 9,709 13, % 7,432 10, % %

書冊1.indb

* % 129, ,280 (22.7) 20,694 55,078 (62.4) 20,230 21,598 (6.3) 170, ,956 (30.2) * % 76, ,742 (30.7) 93, ,214 (29.9) 170,

4 422, ,872 (421,324) (642,374) 1,472 77, ,552 76,388 6 (1,536,513) (511,793) (50,825) (48,211) (271,931) (380,172) (6,591) (3,391) (59,3

i

,473,691 1,084,415 12,778 5,804 (452,982) (331,973) (395,241) (286,732) (66,548) (40,851) (209,777) (152,944) (66,423

2018 Hope Education Group Co., Ltd

SOHO SOHO 34 4,750 4, % 84% 50% 2,697 29% 1, % 26% / 08/ 10/ 13/ 21/ 23/

untitled


3 662, ,888 (68,568) (88,607) 594, ,281 40,205 49,290 (431,939) (358,813) (104,793) (92,393) (19,179) (14,839) (11,375) (11,662) (2,717) (

3 989, , ,861 20,627 (402,840) (380,162) (256,279) (237,601) (55,812) (49,785) (58,153) (51,525) (105,918) (88,123) (68,619) (65,572) 5 (

EJE (HONG KONG) HOLDINGS LIMITED * 8101 GEM GEM GEM GEM GEM GEM GEM GEM GEM GEM GEM GEM (1) (2) * 1

3 748, ,758 3 (517,583) (435,198) 230, ,560 4 (32,567) (33,356) 4 (78,051) (62,928) (821) ,513 97, (8,298) (3,575) 5 (7,3


,152 31, , ,141 5,182 2,803 10,554 6,584 57,095 8, , , , , ,457 67, ,670 38,217 1,130,205 1



ø< ø~ *ø< #+< #ø< * # + ø ~ < FCCA, CPA Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY Cayman Islands Codan Tru


i


Cricket Square Hutchins Drive, P.O. Box 2681 Grand Cayman KY Cayman Islands SMP Partners (Cayman) Limite

公 司 簡 介

5 1,307,639, ,927, ,427,750 27,484,976 (163,402,642) (130,478,323) (110,382,274) (77,483,595) (341,276,031) (277,865,036) (126,932,303) (

Kingwell_C_MT Cir.indb

Transcription:

2010 1164

2 3 4 6 12 14 18 30 32 33 34 36 37 39 2010 12 31 100

12 31 2010 2009 2008 2007 2006 328,120 367,056 699,317 507,494 487,147 52,942 66,171 97,887 77,576 60,217 (779) (586) (16,405) (12,605) (13,201) 52,163 65,585 81,482 64,971 47,016 (12,947) (12,615) (20,563) (14,512) (9,916) 39,216 52,970 60,919 50,459 37,100 36,610 53,010 61,095 50,622 37,743 2,606 (40) (176) (163) (643) 39,216 52,970 60,919 50,459 37,100 12 31 2010 2009 2008 2007 2006 871,860 725,102 794,921 741,037 696,491 (164,845) (74,912) (197,549) (236,995) (250,679) 707,015 650,190 597,372 504,042 445,812 703,601 649,382 596,959 503,453 445,071 3,414 808 413 589 741 707,015 650,190 597,372 504,042 445,812 2010 12 312 20092010 12 3132 35 20092008 12 31 2010 12 31 2010 12 31 02

(ACIS (ICSA), ACS (HKICS), ACCA) 2011 3 31 (CPA (Aust.), CPA) 2011 3 31 89 1 31 7 www.vital-pharm.com 2011 3 31 2011 3 31 Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands HSBC Trustee (Cayman) Limited P.O. Box 484 HSBC House 68 West Bay Road Grand Cayman KY1 1106 Cayman Islands 33 18 03

2010 12 31 2010 328367 11% 201022.6 2010 9.7 37 531631% 2010 5 2010 2010 04

2011 1 Pharmco International, Inc.Pharmco Pharmco 2011 3 28 05

06 2010 328367 11%. 2010 201022.6 2010 9.7 37 531631% 2.3620093.42 2010 12 31 80 11% 2010 2010 5 3.24 3.6411% 2009 2010 206930% 2009 2010 18 2

40 20105.6 411 8% 20102.4 17% 201011 101 20104.1 64% 2cm 2010 2009 20105.7 2.3 2010 20106.7 30% 07

2010 GMP 2011 1 GMP 2010 7 2010 5 49,595 20 2011 2010 4.2 2009 3 08

09 2010 12 31 20 51 2011 12 31 48% 5.6% 5% 10%2009 12 31 2010 12 31 80 2009 12 31 16478% 2009 94%9% 2009 3% 11% 2009 3% 2% 42% 2009 12% 32% 2009 30% 26% 2009 58% 76% 2009 80% 2010 2010 2011 1 Pharmco International, Inc.Pharmco Pharmco 2010 12 311,551,056,993 2009 12 311,551,056,993 2010 20092010 12 31 3.57 2009 12 31 2.84 2010 12 31 71 2009 12 31 802009 12 31164 12 2009 12 31 0.7 2010 12 31 2.59 2009 12 311.67 1.87 2009 12 311.67 6% 20096%

2010 12 312009 2010 1.2 200971% 3% 2010 68% 20.8 8 2010 25%29% 9.7 2009 3.1 8.1 20090.1 81 83 2010 2009 328 367 68% 71% 82 107 43% 42% 11% 14% EBITDA 69 85 EBITDA 21% 23% 2010 2009 11% 10

53 263 2010 12 31 2009 12 31 71 80 164 652 572 11% 0% 53 86 263 215 2010 12 3112.1 62.515.9 78.4 2010 5% 2010 12 3177920 204383 172756 23 2010 69.8 2010 5 6 49,595 204,600,000 2010 6 9 2010 6 25 10 11

47 10 34 2004 10 5 Perfect Develop Holding Inc. 2008 4 49 1982 1990 102000 2002 2003 2009 10 52%2009 11 47 1984 1993 2001 6 2008 1 1 50 1988 2002 2005 49 1982 109 1982 1987 1994 2006 2009 11 48 1998 4 53University of Leeds University of Bradford 12

13 362005 7 2002 2009 2008 2011 3 31 47 11 26 2000 52 1982 20 1998 43 1989 2003California American University EMBA2001 2002 7 481994 2006 4 20 2002 1 44 University of Science, Malaysia 14 2006 10 52 1988 2001 2009 12

14 1/3 3.13 10 2010 12 31 2010 12 316 3 1213 2009 11 11 2009 11 11 3 4 1 1 7 7/7 7/7 3/7 7/7 5/7 5/7 7/7 7/7 7/7 14

3 2010 2010 2005 6 30 2 3 15

5 16 1 1/1 1/1 1/1 1/1 1/1 2002 1 263 2010 4 4/4 4/4 4/4 16

2010 12 31 20 (852) 2570 5886 (852) 2806 2861 89 1 31 3107 2010 12 31 950,000 622,000 17

2010 12 31 2002 2 72003 8 4 8 32 2009 2010 12 312009 2010 12 3152 36 17 18 19 20 40 32 18

108 2004 10 21 2009 11 112004 11 22 2008 1 1 33,000 10% 2011 12 312012 10 18 10,000 19

12 13 2010 12 31279,654,000 2010 2010 6 2 2010 2003 7 232003 2010 17 2010 2010 (1) 2010 (2) 2010 (3) 2010 155,105,6992010 10% 20

(4) 122010 (1%) (5) 2010 (10) (6) 2010 (7) (28) 1.00 (8) 2010 (i)(ii) (5)(iii) (9) 20102010 6 210 21

2003 2002 1 262003 7 232003 2003 2003 2003 30% 2003127,746,216 2003 10%2005 5 31 154,170,699 122003 1% 21 2003 (i)(ii) (iii) 1 2003 20032003 7 23 22

2002 6 2130,000,0000.39 2002 8 162012 2 6 2002 8 162012 2 6 6,850,000 2003 1 12012 2 6 8,280,000 2004 1 12012 2 6 6,510,000 2005 1 12012 2 6 8,360,000 10821,100,00029 8,900,0002010 12 31 2010 12 31 330,000 2003 2 283 19,800,000 0.242012 2 6 2004 2003 9 2930,000,0000.51 2004 1 22012 2 6 2004 1 22012 2 6 8,990,000 2004 7 22012 2 6 21,010,000 1416,595,0005 12,405,0001 1,000,0002003 1,500,0002010 12 31 2010 12 31 13,760,000 23

2005 9 1269,800,0000.23 2006 1 12012 2 6 2006 1 12012 2 6 34,900,000 2007 1 12012 2 6 34,900,000 1211,000,0003 35,000,00034,500,0002 12 18,000,00021,300,000 2010 12 312010 12 31 32,800,000 2008 1 2967,500,0000.28 2008 10 12012 2 6 2008 10 12012 2 6 20,250,000 2009 1 12012 2 6 47,250,000 616,000,0004 34,000,00011,500,0001 2,000,00013,000,0003 11,000,0002010 12 31 2,000,0002010 12 31 65,500,000 2003 9 2215% 28.360% 2004 3 229,433,962 2004 9 229,433,962 2005 3 229,433,962 24

30 0.46 0.46 61,525,839 2005 35 3 15 2010 6 2Vital Pharmaceutical Holdings Limited Vital Group Holdings Limited (a) 2010 12 31 XVXV7 8 352 0.01 1 26,666 (L) 0.0017% 14,630,400 (L) 0.94% 1. L 25

2010 12 31 2010 12 31 2005 9 12 2006 1 1 2012 2 6 2 0.23 15,000,000 2003 9 29 2004 1 2 2012 2 6 3 0.51 3,000,000 2008 1 29 2008 10 1 2012 2 6 4 0.28 8,500,000 2008 1 29 2008 10 1 2012 2 6 4 0.28 8,500,000 2008 1 29 2008 10 1 2012 2 6 4 0.28 1,500,000 2. 2006 1 12012 2 6 2006 1 12006 12 31 50%2007 1 12012 2 6 3. 2004 1 22012 2 6 2004 1 22004 7 1 500,000 2004 7 22012 2 62008 1 1 2003 9 29 4. 2008 10 12012 2 6 2008 10 1 2008 12 3130%2009 1 12012 2 6 XV7 8 352 26

(b) 2010 12 31 336 XV2 3 10% 5 Perfect Develop Holding Inc. 6 522,526,940 (L) 33.69% 5. L 6. Perfect Develop Holding Inc. 58.28% 30.67% 11.05% 2010 12 31 XV2 3 10% 18 27

42% 76% 34% 50% 5% 2010 12 31 52% 115,000 2011 3 28 28

41 2010 3 2011 3 28 29

Vital Pharmaceutical Holdings Limited 3299 2010 12 31 30

2010 12 31 P04798 2011 3 28 31

2010 12 31 2010 2009 8 328,120 367,056 (104,098) (107,345) 224,022 259,711 8 16,230 24,428 (82,178) (107,158) (82,563) (80,828) 23 (22,569) (29,982) 10 (779) (586) 52,163 65,585 11 (12,947) (12,615) 12 39,216 52,970 36,610 53,010 2,606 (40) 39,216 52,970 14 2.36 3.42 2.36 3.42 32

2010 12 31 2010 2009 39,216 52,970 15,589 (3,383) (1,922) 898 13,667 (2,485) 333 1,903 (683) (5) (350) 1,898 5,723 (1,431) 4,292 17,609 (587) 56,825 52,383 54,219 52,423 2,606 (40) 56,825 52,383 33

2010 12 31 2010 2009 17 3,028 3,030 18 174,139 203,015 19 95,409 74,384 20 32,922 38,711 21 4,063 4,201 22 2,331 23 52,355 74,924 361,916 400,596 24 240,561 25 108,968 73,730 26 69,195 69,241 20 672 800 8,091 9,118 5,537 27 2,173 2,121 28 12,138 668 68,146 163,291 509,944 324,506 29 67,148 58,993 3,591 7,746 30 446 31 71,285 149,770 59,439 360,174 265,067 722,090 665,663 34

2010 12 31 2010 2009 32 15,511 15,511 688,090 633,871 703,601 649,382 3,414 808 707,015 650,190 33 920 2,778 34 14,155 12,695 15,075 15,473 722,090 665,663 32 992011 3 28 35

2010 12 31 2009 1 1 15,511 251,175 57,319 9,891 45,593 616 (1,548) 213,683 4,719 596,959 413 597,372 53,010 53,010 (40) 52,970 (2,485) 1,898 (587) (587) (2,485) 1,898 53,010 52,423 (40) 52,383 435 435 2,290 (2,290) 2009 12 31 15,511 251,175 54,834 9,891 47,883 616 350 264,403 4,719 649,382 808 650,190 36,610 36,610 2,606 39,216 13,667 (350) 4,292 17,609 17,609 13,667 (350) 36,610 4,292 54,219 2,606 56,825 6,490 (6,490) 2010 12 31 15,511 251,175 68,501 9,891 54,373 616 294,523 9,011 703,601 3,414 707,015 10% 36

2010 12 31 2010 2009 52,163 65,585 1,335 1,119 672 800 (17,352) 6 (454) 14,367 16,999 779 586 9 (2,099) 898 22,569 29,982 9,702 3,126 1,724 1,497 1,172 (1,544) (995) (343) (663) 8,064 144 1,111 (152) (2,778) (1,493) (3,330) 333 161 951 99,812 104,839 (33,393) (7,697) (239,315) 2,491 56,005 10,622 (13,096) (2,060) 5,728 (5,537) 3,591 (17,522) (150,464) 114,932 (4,372) (20,159) (154,836) 94,773 37

2010 12 31 2010 2009 (11,469) 3,334 (3,994) (1,485) (1,650) (1,778) (1,230) (1,896) 1,972 770 1,544 995 343 663 57 4,623 (14,427) 5,226 94,274 (22,989) (84,349) (2,025) (586) (446) (148) 68,814 (85,083) (100,449) 14,916 163,291 148,351 5,304 24 68,146 163,291 38

2010 12 31 1. 2010 6 2Vital Pharmaceutical Holdings Limited Vital Group Holdings Limited 2010 6 2 2. 27 39 1 1 2 3 5 17 52008 2009 39

2010 12 31 2. 32008 32010 1 1 2010 1 1 27 327 327 327 17 2009 17 17 17 17 172010 1 1 17 5 5 5 40

2010 12 31 2. 2010 3 20087 128 1 1 7 3 1 5 7 5 9 7 12 6 24 4 32 2 4 14 3 19 1 2010 7 12011 1 1 2 2010 2 1 3 2010 7 1 4 2011 1 1 5 2011 7 1 6 2012 1 1 7 2013 1 1 2009 112010 10 9 939 9 9 39 41

2010 12 31 2. 92013 1 1 92013 1 1 7 242009 242009 32 32 14 19 19 19 12 40 12 42

2010 12 31 3. 2010 1 1 43

2010 12 31 3. 2010 1 1 44

2010 12 31 3. 45

2010 12 31 3. 46

2010 12 31 3. 47

2010 12 31 3. 90180 48

2010 12 31 3. 49

2010 12 31 3. 50

2010 12 31 3. 51

2010 12 31 3. 2002 11 7 2002 11 72005 1 1 52

2010 12 31 3. 2002 11 72005 1 1 53

2010 12 31 3. 54

2010 12 31 3. 2010 1 1 55

2010 12 31 3. 56

2010 12 31 4. 3 18 19 24 2010 12 31 52,355,000 94,927,0002009 74,924,000 72,358,00023 57

2010 12 31 4. 2010 12 3142,560,000 7,800,0002009 52,201,000 12,387,000 2010 12 31 138,00026,497,000 3,273,000 2009501,000 20,509,000 16,539,000 4,275,000 2010 12 31108,968,000 4,955,000 2009 73,730,000 4,917,000 2010 12 31 240,561,0002009 58

2010 12 31 4. 2010 12 31 174,139,000 39,903,0002009 203,015,000 30,201,000 11 2010 12 31 18,890,00020098,390,000 5. 30 31 59

2010 12 31 6. 2010 2009 2,331 2,173 2,121 125,202 223,806 117,346 58,556 7. 2010 2009 2010 2009 44 1,346 744 3,982 6,702 584 357 60

2010 12 31 7. 5% 20095%5% 20095% 5% 20095% 5% 20095%5% 2009 5% 2010 2009 2010 2009 229 370 (297) (151) 2010 12 31 2009 12 31 61

2010 12 31 7. 50 50 2010 12 31 86,000 2010 12 31 2010 12 31 100% 2009 100% 62

2010 12 31 7. 12 31 1 1 2010 47,504 46,584 920 47,504 5.78 71,285 74,231 74,231 118,789 120,815 920 121,735 2009 58,110 55,332 2,778 58,110 10.25 446 452 452 58,556 55,784 2,778 58,562 63

2010 12 31 7. 33 2010 2,173 2,173 2009 2,121 2,121 2,331 2,331 2,331 2,121 4,452 20102009 12 31 64

2010 12 31 8. 2010 2009 323,954 364,022 a 4,166 3,034 328,120 367,056 17,352 b 3,497 4,491 1,382 1,544 995 343 663 454 85 3,330 2,099 152 1,493 2,778 16,230 24,428 344,350 391,484 (a) 2010 2009 4,166 3,034 (700) (541) 3,466 2,493 (b) 2009 12 31 65

2010 12 31 9. 24 a) b) 2010 12 31 323,954 4,166 328,120 54,164 2,813 56,977 8,477 (12,512) (779) 52,163 66

2010 12 31 9. 2009 12 31 364,022 3,034 367,056 50,507 19,845 70,352 6,991 (11,172) (586) 65,585 3 2010 2009 435,762 472,819 345,394 74,384 781,156 547,203 90,704 177,899 871,860 725,102 2010 2009 66,153 56,486 216 66,369 56,486 98,476 18,426 164,845 74,912 67

2010 12 31 9. 2010 3,042 605 3,647 1,230 1,230 22,569 22,569 16,368 6 16,374 9,702 9,702 8,064 8,064 41 41 120 120 1,724 1,724 381 381 1,654 1,654 (3,330) (3,330) 9 9 6 6 779 779 12,947 12,947 (1,544) (1,544) (343) (343) 68

2010 12 31 9. 2009 2,176 2,176 2,331 2,331 29,982 29,982 18,898 20 18,918 3,126 3,126 144 144 213 213 738 738 1,172 1,172 1,497 1,497 333 333 1,194 1,194 1,111 1,111 (17,352) (17,352) (663) (663) (454) (454) (995) (995) 586 586 12,615 12,615 10% 2010 2009 1 112,643 127,862 1 69

2010 12 31 10. 2010 2009 1,246 473 6 44 773 42 27 2,025 586 (1,246) 779 586 5.82% 2009 11. 2010 2009 15,920 7,427 (2,739) 13,181 7,427 34 (234) 5,188 12,947 12,615 2000/01 2001/026,031,000 2010 2009 12 31 2009 12 312002/032002 12 31 1,760,000 2009 12 31 1,760,00020102009 12 31 70

2010 12 31 11. 2010 12 312003/042003 12 31 5,250,000 2009 12 312002/032002 12 31 599,000 300,0002009 12 31 20102009 12 31 2010 12 312003/042003 12 31 5,250,000 25% 15% BVIBVI 71

2010 12 31 11. 2010 2009 52,163 65,585 13,998 15,081 (3,851) (9,559) (708) (1,020) 6,208 7,624 (8,205) (1,029) 8,244 1,518 (2,739) 12,947 12,615 34 12. 2010 2009 1,335 1,119 672 800 1,264 1,423 103,237 105,853 14,367 16,999 26 1,172 18 9,702 3,126 26 1,724 1,497 8,064 144 1,654 2,341 1,111 381 1,194 15 69,844 73,244 120 738 41 213 898 333 9 6 72

2010 12 31 13. 2010 12 31 2009 14. 2010 2009 36,610 53,010 1,551,056,993 1,551,056,993 193,633 1,551,250,626 1,551,056,993 2009 12 31 2009 12 31 15. 2010 2009 62,851 61,052 6,993 7,605 4,587 69,844 73,244 2009 12 314,587,000 73

2010 12 31 15. 35 16. (a) 2009 2010 12 31 396 500 12 908 396 500 896 396 500 12 908 396 500 896 396 500 896 396 500 896 120 120 120 120 120 120 360 2,376 3,000 24 5,760 74

2010 12 31 16. (a) 2009 12 31 1 102 650 12 764 158 650 12 820 1 532 650 1,182 1 103 650 753 2 158 650 808 158 650 6 814 3 55 55 3 55 55 3 55 55 120 120 120 120 120 120 360 1,376 3,900 30 5,666 1 2009 11 11 2 2009 11 11 3 2009 11 11 2010 12 31 75

2010 12 31 16. (b) 2009 2009 12 31 1 2009 813 12 825 1,000,000 (c) 2010 12 31 2010 12 31 76

2010 12 31 17. 2009 1 1 14,621 1,896 435 (833) 2009 12 31 16,119 540 1,230 2010 12 31 17,889 2009 1 1 11,970 1,119 2009 12 31 13,089 437 1,335 2010 12 31 14,861 2010 12 31 3,028 2009 12 31 3,030 2009 12 31 833,000 77

2010 12 31 18. 2009 1 1 100,675 7,296 202,062 23,721 12,886 346,640 221 4 225 1,344 492 128 104 108 2,176 (4,030) (4) (4,949) (44) (9,027) 2009 12 31 97,989 7,788 202,186 19,097 12,954 340,014 1,675 48 5,799 593 399 8,514 666 123 1,131 250 1,477 3,647 (545) (8,852) (5,652) (3,296) (18,345) (5,988) (5,988) 2010 12 31 93,797 7,959 200,264 14,288 11,534 327,842 2009 1 1 9,167 5,899 81,009 16,967 8,046 121,088 42 4 46 2,626 749 9,492 2,216 1,916 16,999 3,126 3,126 (171) (3) (4,050) (36) (4,260) 2009 12 31 11,622 6,648 93,624 15,175 9,930 136,999 189 30 2,380 472 261 3,332 3,280 492 6,724 2,386 1,485 14,367 9,702 9,702 (74) (2,108) (5,040) (3,002) (10,224) (473) (473) 2010 12 31 14,544 7,170 110,322 12,993 8,674 153,703 2010 12 31 79,253 789 89,942 1,295 2,860 174,139 2009 12 31 86,367 1,140 108,562 3,922 3,024 203,015 78

2010 12 31 18. 2010 2009 12,357 12,706 11,415 11,970 55,481 61,691 79,253 86,367 40 20% 2.5% 20% 20% 10% 27% (a) 2010 12 3162,457,0002009 40,304,000 (b) 2009 12 31 3,922,000775,000 2010 12 31 (c) 2009 12 31 3,126,000 2010 12 31 9,702,000 2011 1 25 (d) 2010 12 3127,949,000200925,629,000 79

2010 12 31 19. 2009 1 1 57,032 17,352 2009 12 31 74,384 18 e 5,515 e 6,607 e 5,723 3,180 2010 12 31 95,409 (a) (b) (c) 2010 12 31 (d) 2009 12 31 (e) 2010 12 31 5,515,0006,607,000 17,845,000 (f) 2010 12 3178,396,0002009 57,898,000 (g) 2010 12 3117,014,000200917,332,000 80

2010 12 31 20. 2010 2009 672 800 32,922 38,711 33,594 39,511 2010 12 31 15,875,000200916,270,000 21. 20102009 12 3120102009 12 31 37 22. 2010 2009 a 7,072 a (7,072) b 2,331 2,331 (a) 2009 12 31 7,072,000 2010 12 31 (b) 2009 12 312010 12 31 81

2010 12 31 23. 2009 1 12009 12 31 2010 12 31 34,876 112,406 147,282 2009 1 1 34,876 7,500 42,376 29,982 29,982 2009 12 31 34,876 37,482 72,358 22,569 22,569 2010 12 31 34,876 60,051 94,927 2010 12 31 52,355 52,355 2009 12 31 74,924 74,924 34,876,000 2010 12 31 22,569,000200929,982,000 41(i) 19.51% 200918.42%3% 20093% 82

2010 12 31 24. 2010 2009 1 1 240,561 12 31 240,561 237,446 1,869 1,246 240,561 2010 2009 23,745 213,701 237,446 25. 2010 2009 18,157 14,518 30,480 10,638 1,648 305 55,183 46,088 3,500 2,181 108,968 73,730 83

2010 12 31 26. 2010 2009 50,360 64,588 29,770 20,814 a 138 21,010 80,268 106,412 (7,800) (12,387) b (20,509) c (3,273) (4,275) 69,195 69,241 (a) (b) 2009 12 31 20,509,000 2010 12 31 2010 2009 1 1 20,509 20,509 (20,509) 12 31 20,509 2009 12 31 20,509,000 84

2010 12 31 26. (c) 2010 2009 1 1 4,275 2,778 52 1,724 1,497 (2,778) 12 31 3,273 4,275 2010 12 313,273,0002009 4,275,000 90180 2010 2009 30 13,755 13,979 31 60 18,381 14,823 61 90 10,161 12,998 90 263 10,401 42,560 52,201 2010 2009 1 1 12,387 11,215 251 1,172 (152) (4,686) 12 31 7,800 12,387 2010 12 317,800,0002009 12,387,000 85

2010 12 31 26. 20102009 12 31 90 91 180 181 365 1 2 2010 12 31 42,560 42,560 2009 12 31 52,201 41,800 10,401 20102009 12 31 27. 2010 2009 2,173 2,121 28. 2010 12 3162,576,0002009152,793,000 0.2920090.90 0.011.9820090.050.72 86

2010 12 31 29. 2010 2009 19,576 5,462 47,572 53,531 67,148 58,993 2010 2009 30 16,448 5,008 31 60 946 60 61 90 1,797 28 90 385 366 19,576 5,462 30200930 2008 11 12 2010 2009 1 1 2,500 5,556 86 1,111 (1,139) (4,167) 12 31 1,447 2,500 87

2010 12 31 30. 2009 12 31 452 446 (6) 446 446 10.25 2010 12 31 31. 2010 2009 34,483 36,802 71,285 2010 12 315.58 5.856.12 38 2010 2009 187,336 166,667 88

2010 12 31 32. 0.01 2009 1 12009 12 312010 12 31 50,000,000,000 500,000 2009 1 12009 12 312010 12 31 1,551,056,993 15,511 33. 2008 2010 2009 1,494 2,666 920 2,778 2,414 5,444 2012 12 31 89

2010 12 31 34. 2009 1 1 4,974 1,529 1,573 (569) 7,507 341 4,338 509 5,188 2009 12 31 5,315 5,867 1,573 (60) 12,695 (132) (40) (62) (234) 1,431 1,431 11 202 50 263 2010 12 31 5,194 6,029 3,054 (122) 14,155 97,504,000200989,910,000 739,0002009364,000 96,765,000200989,546,0002010 12 31 31,638,000200928,331,000 60,370,000200974,904,000 2008 1 1 13,448,00020099,307,000 90

2010 12 31 35. 2002 1 26200220022003 7 232003 2010 6 22010 20032003 2010 4 27 30% 2010 10% 121% 12 0.1%5,000,000 2010 12 31 112,390,0002009 114,390,0007.25% 20097.37% 20102009 12 312,000,000 91

2010 12 31 35. 2002 6 2130,000,0002002 0.390.37 2002 8 162012 2 6 2002 8 162012 2 6 6,850,000 2003 1 12012 2 6 8,280,000 2004 1 12012 2 6 6,510,000 2005 1 12012 2 6 8,360,000 2003 2 2819,800,0002002 0.240.21 2003 3 12012 2 6 2003 9 2930,000,0002003 0.510.50 2004 1 22012 2 6 2004 1 22012 2 6 8,990,000 2004 7 22012 2 6 21,010,000 2005 9 1269,800,0002003 0.230.23 2006 1 12012 2 6 2006 1 12012 2 6 34,900,000 2007 1 12012 2 6 34,900,000 2008 1 2967,500,0002003 0.280.28 2008 10 12012 2 6 2008 10 12012 2 6 20,250,000 2009 1 12012 2 6 47,250,000 92

2010 12 31 35. 2009 1 1 2009 2010 12 31 12 31 2005 9 12 15,000,000 15,000,000 0.23 2008 1 29 8,500,000 8,500,000 0.28 2003 9 29 3,000,000 3,000,000 0.51 2008 1 29 8,500,000 8,500,000 0.28 1 2005 9 12 15,000,000 15,000,000 0.23 1 2008 1 29 8,500,000 8,500,000 0.28 1 2008 1 29 8,500,000 8,500,000 0.28 2008 1 29 1,500,000 1,500,000 0.28 2002 6 21 330,000 330,000 0.39 2003 9 29 10,260,000 10,260,000 0.51 2005 9 12 2,800,000 2,800,000 0.23 2008 1 29 21,000,000 (2,000,000) 19,000,000 0.28 2003 9 29 500,000 500,000 0.51 2008 1 29 11,000,000 11,000,000 0.28 114,390,000 (2,000,000) 112,390,000 114,390,000 112,390,000 0.29 0.28 0.29 1 2009 11 112012 2 6 93

2010 12 31 36. (a) 2002 1 30 2002 2 7 (b) 2010 2009 8,922 7,333 109 101 9,031 7,434 37. (a) 2010 2009 940 4,014 (b) 2010 2009 571 94

2010 12 31 37. (c) 2010 2009 230 759,439 759,669 (d) 4,166,00020093,034,000 4.37% 20094.08% 2010 2009 3,236 1,016 5,974 1,895 9,210 2,911 12 2010 2009 905 715 562 16 1,467 731 95

2010 12 31 38. 2010 2009 62,457 40,304 78,396 57,898 12,138 668 15,875 16,270 168,866 115,140 39. 2010 2009 13 21 2,331 53,035 53,035 53,048 55,387 144 349 (a) 381,016 399,848 4,811 5,038 385,971 405,235 5,290 5,285 (a) 128,673 135,763 133,963 141,048 252,008 264,187 305,056 319,574 15,511 15,511 314,098 314,448 (24,553) (10,385) 305,056 319,574 (a) 96

2010 12 31 40. 20102009 12 31 2010 2009 Ever Power Holding Inc. BVI BVI 2 1 100% 100% Gainful Plan Limited BVI BVI 2 1 100% 100% 2 1 100% 100% BVI 103 1 100% 100% Beshabar Trading Limited BVI BVI 11 100% 100% Beshabar (Macao Commercial Offshore) Limited 1 100,000 100% 100% Beshabar Trading Limited 100 1 100% 100% 100 1 100% 100% Wuhan Weiao Pharmaceuticals Co., Ltd. 30,000,000 95.70% 95.70% # 221,080,754 100% 100% # 1,400,000 100% 97

2010 12 31 40. 2010 2009 Wide Triumph Limited 100 1 100% 100% Vital Pharmaceuticals Company Limited 100 1 100% 100% # 7,000,000 25,000,000 100% 100% 4,300,000 100% 100% # 18,000,000 100% 8,000,000 100% # 98

2010 12 31 40. 2010 12 31 Darsawye Pty Limited 2009 12 31 2010 12 31 25,000,0007,000,000 18,000,000 41. (i) 2011 1 24Pharmco International, Inc.Pharmco Ph armco 2010 12 7Pharmco 2011 1 25 (ii) 2011 1 28 21,000,000 2010 12 31 11,415,000 2011 1 28 (iii) 2011 3 182011 3 28 42. 9 99

2010 12 31 318 1215 16 4 1 12 3 WJ01 (252/211): 2010 035 49,595.3 100% 100